|
Market Closed -
Nasdaq
01:30:00 17/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 62.23 USD | -0.95% |
|
+3.96% | +41.98% |
| 09/10 | Exelixis' Zanzalintinib Clinical Trials for Cancer Highly Likely to Succeed, RBC Says | MT |
| 09/10 | RBC Raises Price Target on Exelixis to $51 From $45, Keeps Sector Perform Rating | MT |
| Market Cap | 1.54TCr 1.37TCr 1.27TCr 1.16TCr 2.18TCr 1,46300Cr 2.22TCr 15TCr 5.99TCr 76TCr 5.79TCr 5.66TCr 2,43400Cr | P/E 2026 * |
19.3x | P/E 2027 * | 15.9x |
|---|---|---|---|---|---|
| Enterprise Value | 1.47TCr 1.3TCr 1.21TCr 1.1TCr 2.08TCr 1,39300Cr 2.11TCr 15TCr 5.7TCr 73TCr 5.51TCr 5.39TCr 2,31700Cr | EV / Sales 2026 * |
5.75x | EV / Sales 2027 * | 4.75x |
| Free-Float |
98.15% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| EXEL | Delayed | |
CBOE
| EXEL | Real-time | |
|
Tradegate
| EX9 | Real-time | |
|
Boerse Muenchen
| EX9 | Real-time | |
|
Deutsche Boerse AG
| EX9 | Delayed | |
|
Borsa Italiana
| 1EXEL | End-of-day quote | |
|
Börse Stuttgart
| EX9 | Delayed | |
|
Berne S.E.
| EX9 | End-of-day quote |
Last Transcript: Exelixis, Inc.
| 1 day | -0.95% | ||
| 1 week | +3.96% | ||
| Current month | +6.54% | ||
| 1 month | +9.60% | ||
| 3 months | +11.76% | ||
| 6 months | +40.22% | ||
| Current year | +41.98% |
| 1 week | 58.59 |  | 63.39 |
| 1 month | 56.26 | | 63.39 |
| Current year | 39.71 | | 63.39 |
| 1 year | 33.76 | | 63.39 |
| 3 years | 18.64 | | 63.39 |
| 5 years | 14.87 | | 63.39 |
| 10 years | 10.04 | | 63.39 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 22/07/2010 | |
| Director of Finance/CFO | 58 | 15/07/2015 | |
Dana Aftab
COO | Chief Operating Officer | 63 | 01/02/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 01/02/2004 | |
George Poste
BRD | Director/Board Member | 82 | 01/08/2004 |
| Chairman | 77 | 01/01/1998 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/08/26 | Sell | Director | -9,812 | 0.0039% | ||
| 01/06/26 | Sell | Director | -9,812 | 0.0039% | ||
| 01/06/26 | Sell | Director | -3,925 | 0.0016% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.95% | +3.96% | +58.71% | +188.50% | 1.56TCr | |
| -6.60% | -8.56% | +42.79% | +64.16% | 6.9TCr | |
| -4.09% | -0.11% | +2.31% | +54.81% | 5.31TCr | |
| +0.03% | +5.56% | +10.18% | +41.75% | 5.08TCr | |
| -1.53% | +2.70% | +29.72% | +34.13% | 4.46TCr | |
| -1.34% | +4.12% | +16.05% | +112.18% | 4.25TCr | |
| -5.97% | -6.22% | +258.21% | +421.57% | 4.06TCr | |
| +6.53% | +8.02% | +15.74% | +53.94% | 3.09TCr | |
| -0.90% | -10.49% | +31.48% | -1.63% | 2.54TCr | |
| -2.76% | -9.54% | -16.53% | -9.55% | 2.27TCr | |
| Average | -1.76% | +0.05% | +44.86% | +95.99% | 3.95TCr | |
| Weighted average by Cap. | -2.37% | +0.06% | +45.29% | +94.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 255.43Cr 227.05Cr 210.45Cr 191.47Cr 361.31Cr 24TCr 367.1Cr 2.53TCr 991.81Cr 13TCr 958.63Cr 938.22Cr 40TCr | 290.21Cr 257.97Cr 239.1Cr 217.54Cr 410.51Cr 28TCr 417.09Cr 2.87TCr 1.13TCr 14TCr 1.09TCr 1.07TCr 46TCr |
| Net income | 82Cr 73Cr 68Cr 61Cr 116.04Cr 7.79TCr 117.9Cr 812.45Cr 318.54Cr 4.06TCr 307.89Cr 301.33Cr 13TCr | 100.24Cr 89Cr 83Cr 75Cr 141.79Cr 9.51TCr 144.06Cr 992.68Cr 389.21Cr 4.96TCr 376.19Cr 368.18Cr 16TCr |
| Net Debt | -74Cr -66Cr -61Cr -56Cr -105.31Cr -7.07TCr -107Cr -737.28Cr -289.07Cr -3.69TCr -279.4Cr -273.45Cr -12TCr | -162.27Cr -144.24Cr -133.69Cr -121.64Cr -229.53Cr -15TCr -233.21Cr -1.61TCr -630.07Cr -8.04TCr -608.99Cr -596.02Cr -26TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | $62.23 | -0.95% | 26,37,470 |
| 15/26/15 | $62.83 | +3.02% | 27,73,889 |
| 14/26/14 | $60.99 | +2.49% | 27,53,064 |
| 13/26/13 | $59.51 | -0.52% | 26,24,725 |
| 12/26/12 | $59.82 | -0.07% | 31,28,855 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EXEL Stock
Select your edition
All financial news and data tailored to specific country editions
